Delivery Order SPE2DB20D3101-SPE2DB24FRTX8

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.36 firm fixed-price delivery order is for the supply of 1,000 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,862.93, is for the delivery of Metoprolol Succinate Extended-Release Tablets in quantities of 1,000. The contract has an ultimate completion date of March 6, 2024 and is a firm-fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.29 firm fixed price delivery order covers the supply of 4,558,966,079 units of the prescription medication Metoprolol Succinate Extended-Release 100 mg tablets. The award has an ultimate completion date of November 3, 2022 and was made on November 2, 2022. This delivery order is part of Amerisourcebergen's...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,046.68 firm fixed-price contract is for the delivery of 1,000 tablets of Metoprolol Succinate Extended-Release 100 mg, a medication used to treat cardiovascular conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,604.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of metoprolol succinate extended-release tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The order is for Metoprolol Succinate Extended Release 25 mg tablets, a cardiovascular medication, with a ceiling value of $1,568.34. The contract has a period of performance through September 9, 2024 and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPX14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,570,659 units of Metoprolol Succinate Extended-Release 50 mg tablets, a cardiovascular medication, with a ceiling value of $2,001.78. The contract is a Firm Fixed Price Delivery Order with a term extending through March 14, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,743.51 firm fixed-price delivery order is for the supply of 4,559,461,647 units of Metoprolol Succinate ER 25 mg tablets. The award has an ultimate completion date of December 29, 2022 and was made on December 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRTX8
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,535.67 firm fixed price delivery order is for the supply of 100mg Metoprolol Succinate Extended-Release tablets, a cardiovascular medication. The contract has a period of performance through September 6, 2024. This award is a standalone delivery order and does not appear to be associated with a larger contract vehicle. The contract did not utilize any set-aside designations, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for providing the specified pharmaceutical product to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA.

Generated 2/27/25, 1:13 PM